Yearly Archives: 2016

Prescription Drug Use and Material Misrepresentations

Life Insurance Ramifications of DNA Sequencing

The rise in prescription drug use in the United States has had a direct impact on life insurance claims. The Center for Disease Control recently released figures, from May 8, 2013, that indicate that over 22,000 deaths occur from pharmaceutical drugs each year, of which over 16,500 are related to opioid analgesic overdoses.

MetLife v. Glenn, Hogan-Cross, and Outside Consultants

Life Insurance Ramifications of DNA Sequencing

In assessing life insurance claims, insurers routinely use “independent” or “outside” consultants to substantiate their positions. When litigation arises, discovery into these individuals typically centers on their compensation. Trief & Olk recently had success arguing that beyond plain compensation figures, the number of claims reviewed and subsequent denial statistics were integral in evaluating potential biases.

ERISA Standard of Review

Don’t Lose Life Insurance Coverage When you Need it Most – When you are Gravely ill

In Firestone Tire & Rubber Co. v. Bruch, the Supreme Court set forth a rubric controlling judicial review of ERISA benefit eligibility decisions. Under Firestone, courts are to be guided by principles of trust law in evaluating the conclusions of plan administrators. These principles of trust law require courts to review a denial of plan benefits under a “de novo” standard unless the plan provides to the contrary.